- Active not recruiting
Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis
This study looks at how a medicine called filgotinib works for people with rheumatoid arthritis in everyday life. Researchers want to see if it makes a difference to symptoms, side effects, and how patients feel, simply by observing those already taking the medication.
For: Rheumatoid ArthritisBelgium · Germany · Italy - Active not recruiting
Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)
This study looks at how a medicine called filgotinib works for people with ulcerative colitis in everyday life. Researchers want to see if it helps with symptoms, improves quality of life, and if it's safe for people with moderate to severe disease.
For: Ulcerative ColitisAustria · Belgium · France - RecruitingPHASE1
Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)
This study looks at how a medicine called filgotinib works in the bodies of children and teenagers with a type of arthritis called Juvenile Idiopathic Arthritis (JIA). We want to understand how much medicine is needed and if it's safe for them.
For: Juvenile Idiopathic ArthritisFrance · Germany · Poland - RecruitingPHASE3
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
This study is looking at a new medicine called filgotinib for children and teenagers aged 8 to 18 with moderate to severe ulcerative colitis. It aims to see how well it works, if it's safe, and how the body handles it, compared to what we already know about its use in adults.
For: Ulcerative ColitisBelgium · Croatia · France - Active not recruitingPHASE3
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
This study looks at the long-term safety of a medicine called filgotinib for adults with ulcerative colitis. It's for people who have already been in another filgotinib study. The main goal is to see if taking filgotinib over a longer time is safe.
For: Ulcerative ColitisUnited States · Argentina · Australia - Not yet recruitingPHASE3
Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Idiopathic Arthritis in Children and Adolescents
This study is looking at a new medicine called filgotinib for children and teenagers aged 8-18 who have a type of arthritis called polyarticular-course juvenile idiopathic arthritis (JIA). It aims to see if the medicine is safe, well-tolerated, and helps with their symptoms.
For: Polyarticular Course Juvenile Idiopathic ArthritisUnited Kingdom - RecruitingPHASE3
OLE Study With Filgotinib in JIA
This study looks at the long-term safety and effects of a medicine called filgotinib in children and young people with arthritis. It's for those who have already seen good results from filgotinib in previous studies.
For: Juvenile Idiopathic Arthritis (JIA)France · Germany · United Kingdom - Active not recruitingPHASE3
A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis
This study is looking at a new medication, filgotinib, for people with active axial spondyloarthritis (axSpA). We want to see if it helps reduce symptoms and is safe, comparing different doses to a dummy pill.
For: Axial SpondyloarthritisBelgium · Bulgaria · Czechia